There is increasing evidence that patients with Coronavirus disease 19 (COVID‐19) present
with neurological and psychiatric symptoms. Anosmia, hypogeusia, headache, nausea and …

Abstract Coronavirus disease 2019 (COVID-19) is emerging as the greatest public health
crisis in the early 21 st century. Its causative agent, Severe Acute Respiratory Syndrome …

Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness …

Objective In this systematic review, we will discuss the evidence on the occurrence of central
nervous system (CNS) involvement and neurological manifestations in patients with COVID …

Coronavirus 2019 (COVID-19) is currently the center of what has become a public health
crisis. While the virus is well-known for its trademark effects on respiratory function …

Introduction COVID-19-infected patients harbour neurological symptoms such as stroke and
anosmia, leading to the hypothesis that there is direct invasion of the central nervous system …

Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been associated with many neurological …

The Coronavirus disease due to SARS-CoV-2 emerged in Wuhan city, China in December
2019 and rapidly spread to more than 200 countries as a global health pandemic. There are …

Abstract SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2), the new
coronavirus responsible for the pandemic disease in the last year, is able to affect the central …

Introduction The past two decades have been marked by three epidemics linked to
emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological …